PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge

Clinical trial NCT04754802 · COMPLETED

Trial details

NCT number: NCT04754802
Sponsor: VistaGen Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Social Anxiety Disorder

Start date: 2021-05-24
Primary completion: 2022-06-22
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.